Baranick Brian

EVP, GM, Precision OncologyEXACT SCIENCES CORP (EXAS) · full profile →Form 4 · filed Dec 30, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
21
16 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 24, 2025Tax withholding(F)15K$101.59$1.5M104K
Dec 24, 2025Grant(A)29K$0119K
Dec 23, 2025Tax withholding(F)5K$101.82$489K29K
Dec 23, 2025Option exercise(M)15K$044K
Dec 23, 2025Tax withholding(F)8K$101.82$768K36K
Dec 23, 2025Option exercise(M)29K$065K
Dec 23, 2025Tax withholding(F)15K$101.82$1.5M50K
Dec 23, 2025Option exercise(M)16K$066K
Dec 23, 2025Tax withholding(F)8K$101.82$830K58K
Dec 23, 2025Grant(A)43K$0101K
Dec 23, 2025Tax withholding(F)22K$101.82$2.2M79K
Dec 23, 2025Grant(A)21K$0100K
Dec 23, 2025Tax withholding(F)10K$101.82$1.1M89K
Dec 23, 2025Option exercise(M)4K$026K
Dec 23, 2025Tax withholding(F)2K$101.82$205K24K
Dec 23, 2025Option exercise(M)9K$034K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2025Option exercise(M)4K$00
Dec 23, 2025Option exercise(M)9K$00
Dec 23, 2025Option exercise(M)29K$00
Dec 23, 2025Option exercise(M)15K$00
Dec 23, 2025Option exercise(M)16K$00

Transaction Codes

F
Shares withheld for taxes
A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-337155) within minutes of acceptance. Every field above traces to the original document. Verify it directly: